Novavax Recognized by Washington Post as Top Workplace
17 June 2016 - 10:30PM
GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE)
-- Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third
consecutive year, it has been recognized as a Top Workplace for
2016.
"At Novavax, we strive to create an environment
where teamwork and collaboration thrive based on a culture that
values and appreciates its employees," said Stanley C. Erck,
President and CEO. "We have an incredibly motivated team that is
driven to improve global health through the development of safe and
effective vaccines. We are committed to making Novavax one of the
Top Workplaces for years to come."
The Washington Post Top Workplaces are determined
solely on employee feedback via an employee survey conducted by
WorkplaceDynamics, LLP, a leading research firm on organizational
health and employee engagement.
Jill Hoyt, Vice President, Human Resources, said,
"We are especially proud to be recognized because our talented and
engaged workforce is our most important asset. We believe that all
good outcomes begin with happy employees and we are honored to
receive this recognition from the Washington Post for the third
consecutive year."
The Washington Post publishes the complete list of
Top Workplaces on June 16, 2016. For more information about the Top
Workplaces lists, please visit www.topworkplaces.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M(TM) adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#2021062
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From May 2023 to May 2024